Ecovia Bio ramps up production

The US biotech company has closed a Series B funding round led by Pointe Angels, an independent investors’ club, to significantly increase production capacity at its Livonia facility in Michigan. The aim is to meet growing global demand for its biodegradable biopolymers based on gamma-polyglutamic acid, which are designed to replace petrochemical polymers in cosmetics.